A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty

Journal of Bone and Joint Surgery

Volumn 86, Issue 7, 2004, Pages 1512-1518

  Pierson, Jeffery L ^a   Hannon, Timothy J ^b   Earles, Donald R ^a  

^a St Vincent Center for Joint Replacement   (United States)

^b ST VINCENT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ANEMIA; BLEEDING; BLOOD TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT PLANNING;

EID: 3042744123     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200407000-00022     Document Type: Review

References (52)

1. Feagan BG, Wong CJ, Lau CY, Wheeler SL, Sue-A-Quan G, Kirkley A. Transfusion practice in elective orthopaedic surgery. Transfus Med. 2001;11:87-95.
2. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized multicenter study. J Bone Joint Surg Am. 1999;81:1580-8.
3. Keating EM, Meding JB, Faris PM, Ritter MA. Predictors of transfusion risk in elective knee surgery. Clin Orthop. 1998;357;50-9.
4. Nelson CL, Bowen WS. Total hip arthroplasty in Jehovah's Witnesses without blood transfusion. J Bone Joint Surg Am. 1986;68:350-3.
5. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81:2-10.
6. Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000;93:242-55.
7. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med. 1999;340:438-47.
8. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med. 1998;122:145-51.
9. Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J. Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion. 1995;35:719-22.
10. Blumberg N, Kirkley SA, Heal JM. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg. 1996;171:324-30.
11. Manner PA, Rubash HE, Herndon JH. Prospectus. Future trends in transfusion. Clin Orthop. 1998;357:101-15.
12. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, Fink A, Brook R. The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332:719-24.
13. Atlas SJ, Singer DE, Skates SJ. Changing blood use in the AIDS era: the case of elective hip surgery. Transfusion. 1994;34:386-91.
14. Welch HG, Meehan KR, Goodnough LT. Prudent strategies for elective red blood cell transfusion. Ann Intern Med. 1992;116:393-402.
15. Giordano GF, Dockery J, Wallace BA, Donohoe KM, Rivers SL, Bass LJ, Fretwell RL, Huestis DW, Sandler SG. An autologous blood program coordinated by a regional blood center: a 5-year experience. Transfusion. 1991;31:509-12.
16. Consensus conference. Perioperative red blood cell transfusion. JAMA. 1988;260:2700-3.
17. Toy PT, Strauss RG, Stehling LC, Sears R, Price TH, Rossi EC, Collins ML, Crowley JP, Eisenstaedt RS, Goodnough LT, Greenwalt TS, Johnston MFM, Kennedy MS, Lenes BA, Lusher JM, Mintz PO, Patten ED, Simon TL, Westphal RG. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med. 1987;316:517-20.
18. Autologous blood transfusions. Council on Scientific Affairs. JAMA. 1986;256:2378-80.
19. Lee SJ, Liljas B, Churchill WH, Popovsky MA, Stowell CP, Cannon ME, Johannesson M. Perceptions and preferences of autologous blood donors. Transfusion. 1998;38:757-63.
20. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am. 1996;78:1260-70.
21. Chun TY, Martin S, Lepor H. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology. 1997;50:727-32.
22. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am. 2002;84:1299-304.
23. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts-blood conservation. N Engl J Med. 1999;340:525-33.
24. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion. 1993;33:544-51.
25. Forgle MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med. 1998;158:610-6.
26. Kanter MH, van Maanen D, Anders KH, Castro F, Mya WW, Clark K. Preoperative autologous blood donations before elective hysterectomy. JAMA. 1996;276:798-801.
27. Cohen JA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion. 1995;35:640-4. Erratum in: Transfusion 1996;36:1036.
28. Cohen JA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion. 1995;35:640-4. Erratum in: Transfusion 1996;36:1036.
29. Biesma DH, J Kraaijenhagen RJ, Marx JJ, van de Wiel A. The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors. Transfusion. 1993;33:825-9.
30. Goodnough LT, Brittenham GM. Limitations of erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med. 1990;115:28-35.
31. Feagan BG, Wong CJ, Johnston WC, Arellano R, Colterjohn N, Karkouti K, Turner K. Transfusion practices for elective orthopedic surgery. CMAJ. 2002:166:310-4.
32. Kanter MH, van Maanen D, Anders KH, Castro F, Win Mya W, Clark K. A study of an educational intervention to decrease inappropriate preoperative autologous blood donation: its effectiveness and the effect on subsequent transfusion rates in elective hysterectomy. Transfusion. 1999;39:801-7.
33. Miller RD, von Ehrenburg W. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: con. Transfusion. 1995;35:450-2.
34. Gould SA, Forbes JM. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: pro. Transfusion. 1995;35:446-9.
35. Wasman J, Goodnough LT. Autologous blood donation for elective surgery. Effect on physician transfusion behavior. JAMA. 1987;258:3135-7.
36. Torella F, Haynes SL, Bennett J, Sewell D, McCollum CN. Can hospital transfusion committees change transfusion practice? J R Soc Med. 2002;95:450-2.
37. Toy PT, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC. Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion. 1992;32:63-7.
38. Faris PM, Ritter MA. Epoetin alfa: a bloodless approach for the treatment of periperative anemia. Clin Orthop. 1998;357:60-7.
39. Nuttall GA, Santrach PJ, Oliver WC Jr, Horlocker TT, Shaughnessy WJ, Cabanela ME, Bryant S. The predictors of red cell transfusions in total hip arthroplasties. Transfusion. 1996;36:144-9.
40. Hannon TJ, editor. St. Vincent adult transfusion orders. Indianapolis, IN: St. Vincent Hospitals and Health Services; 1999.
41. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest. 1995;108:767-71.
42. Adams RC, Lundy JS. Anesthesia in cases of poor surgical risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet. 1942;74:1011-9.
43. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. Erratum in: N Engl J Med. 1999;340:1056.
44. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. Erratum in: N Engl J Med. 1999;340:1056.
45. Goodnough LT, Monk TG, Brecher ME. Autologous blood procurement in the surgical setting: lessons learned in the last 10 years. Vox Sang. 1996;71:133-41.
46. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med. 2000;133:845-54.
47. Phillips CB, Barrett JA, Losina E, Mahomed NN, Lingard EA, Guadagnoli E, Baron JA, Harris WH, Poss R, Katz JN. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am. 2003;85:20-6.
48. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2003;85:27-32.
49. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96:1140-6. Erratum in: Anesthesiology. 2002;97:531.
50. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96:1140-6. Erratum in: Anesthesiology. 2002;97:531.
51. Goodnough LT. Erythropoietin therapy versus red cell transfusion. Curr Opin Hematol. 2001;8:405-10.
52. Gill GS, Mills D, Joshi AB. Mortality following primary total knee arthroplasty. J Bone Joint Surg Am. 2003;85:432-5.